Cargando…
Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patients
Initially, most ovarian tumors respond to the treatment with platinum components, but frequently recurrence occurs within the following two years in advanced ovarian cancer patients. In this regard, previous studies have shown changes in the epigenetic patterns in ovarian cancer that are linked with...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992637/ https://www.ncbi.nlm.nih.gov/pubmed/35582723 http://dx.doi.org/10.20517/cdr.2019.010 |